Spellman @AMTZ spells a new Dawn in X-ray Technology in India

Visakhapatnam:  Spellman, the world’s leading manufacturer of X-ray generators, is bringing its state-of-the-art manufacturing facility to the Andhra Pradesh MedTech Zone (AMTZ), marking a significant boost to India’s med-tech capabilities.

As the largest independent supplier of X-ray generators globally, Spellman’s decision to establish its first Indian facility at AMTZ reinforces the zone’s position as a hub for cutting-edge healthcare technology. The company, with a legacy dating back to 1947, has a strong presence across North America, Europe, and Asia and is trusted by Original Equipment Manufacturers (OEMs) for its expertise in medical, industrial, and scientific applications.

The formal commencement of Spellman’s facility setup was marked by a Bhoomi Poojan ceremony at the AMTZ campus, attended by representatives from Spellman’s global leadership, including Mr. Robert J. Frankland, VP Sales from the USA, Ms. Stephanie from China and Arindam Bose from Spellman India.

Emphasizing the significance of this collaboration, Dr. Jitendra Sharma, MD and Founder CEO, AMTZ, said, ‘Having Spellman join Medtech Zone is a monumental step forward for India’s medtech industry. Their Expertise in X-ray technology will drive innovation and strengthen our mission to make healthcare technologies more accessible and affordable.

Spellman’s facility will be the first of its kind in India, manufacturing high-precision X-ray generators and advancing the country’s capabilities in healthcare technology. With over 2,100 employees worldwide and a reputation for innovation, Spellman is expected to catalyze new opportunities for collaboration, knowledge transfer, and economic growth in the region.

The addition of Spellman to AMTZ’s ecosystem highlights the zone’s growing prominence as a destination for global healthcare manufacturers. By fostering partnerships with international leaders like Spellman, AMTZ is paving the way for India to emerge as a key player in the global med-tech industry.

Related Posts

Wow! What a Change of Heart in Practitioners of Allopathy!

New Delhi:  Freedom from drugs is the craving of every diabetic or hypertensive patient. Ask your allopathy doctor, he will warn you of fatal consequences. Once you have started taking…

Twin Health bats a1000 before enters Digital Health NY 100

New Delhi:  Twin Health, an AI enabled Whole Body Digital Twin Technology US company, has earned a place of pride in Digital Health New York’s 100. It certainly is a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wow! What a Change of Heart in Practitioners of Allopathy!

Wow! What a Change of Heart in Practitioners of Allopathy!

GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gain 20% following strong Q3FY25 results

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

US Tariffs on pharma: What are the potential impact on Indian drugmakers

US Tariffs on pharma: What are the potential impact on Indian drugmakers

Twin Health bats a1000 before enters Digital Health NY 100

Twin Health bats a1000 before enters Digital Health NY 100

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%